A very interesting article was recently published in the Swedish medical journal “Läkartidningen” as a comment to the Swedish National Board and Welfare’s decision not to recommend public screening for prostate cancer. In this article it is made clear that screening would lead to increasing overtreatment and complications.
“The problem with overdiagnosis is that the PSA test is not sufficiently accurate to be a good screening test. The most common reason for a moderately increased PSA-value is benign prostatic enlargement – not cancer. The screening program evaluated means that men with PSA-values above a certain level undergo systematic tissue tests from the prostate. Because small areas of prostate cancer are very common in middle-aged men and older men, systematic tissue tests lead to a large number of men receiving diagnosis and treatment, even though they would not have developed a severe prostate cancer during their lifetime. The treatment often causes impaired sexual function and sometimes urinary leakage or rectum problems.”
For the full text click the link below: